Mode
Text Size
Log in / Sign up
N/A N=42 Randomized Triple-blind Treatment

Ultrasound-Assisted Paravertebral Block v. Traditional Paravertebral Block For Pain Control

Paravertebral Peripheral Nerve Block · Acute Pain Management

Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Jan 2019
Primary outcome: Primary: Opioid Consumption at 24 Hours Postoperatively — 5.75; 6.38 mg — p=0.643

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Thoracotomy (Procedure); Video-Assisted Thoracoscopic Surgery (VATS) (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Pittsburgh
Primary completion
Jun 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Opioid Consumption at 24 Hours Postoperatively
5.75; 6.38 0.643
SECONDARY
Sensory Level
3; 1
SECONDARY
Pain 11-point Numerical Rating Scale (NRS)at Rest and With Deep Breathing
1.73; 2.92; 4; 4.77 .077
SECONDARY
Number of Local Anesthetic Boluses Requested by PCA
27.5; 48 0.605
SECONDARY
Total Local Anesthetic Infusions Over 24- Hour Period
173; 186 0.104
SECONDARY
Inspired Oxygen Concentration and Blood Oxygen Saturation (SpO2)
95; 94 0.308
SECONDARY
Incentive Spirometry
0.658; 0.716 0.487
SECONDARY
Respiratory Rate
17; 17.7 0.493
SECONDARY
Forced Vital Capacity (FVC)
0.551; 0.504 0.574
SECONDARY
Forced Expiratory Volume in 1 Sec (FEV1)
0.561; 0.571 0.913
SECONDARY
Peak Expiratory Flow Rate(PEF)
0.568; 0.542 0.783
SECONDARY
Total Number of Local Anesthetic Boluses in 24 Hours
1; 2

Summary

The overall purpose of this research study is to compare the effectiveness of ultrasound assisted paravertebral block placement versus traditional "blind" technique for postoperative analgesia following thoracotomy or visually assisted thoracoscopic surgery.

Eligibility Criteria

Inclusion Criteria

  • 1. American Society of Anesthesiologists (ASA) I-III subjects
  • 2. Ages 18-75 years
  • 3. BMI < 40
  • 4. Scheduled for elective thoracic surgery at University of Pittsburgh Medical Center (UPMC) Passavant and Shadyside Hospitals in Pittsburgh, Pennsylvania
  • 5. Patients willing and able to provide informed consent

Exclusion Criteria

  • 1) Age younger than 18 years or older than 75 years
  • (2) Any contraindication to the placement of unilateral thoracic paravertebral catheter, including local infection, hypocoagulable state.
  • (3) American Society of Anesthesiologists physical status IV or greater
  • (4) chronic painful conditions
  • (5) preoperative opioid use
  • (6) coagulation abnormalities or patients who are expected to be on therapeutic anticoagulants postoperatively
  • (7) allergy to lidocaine, ropivacaine or bupivacaine
  • (8) personal or family history of malignant hyperthermia
  • (9) serum creatinine greater than 1.4 g/dl
  • (10) pregnancy or lactating.The pregnancy status will be determined by history and prior pregnancy testing when appropriate
  • (11) having an altered mental status (not oriented to place, person, or time) or emergency surgery
  • (12) comorbid conditions such as sepsis, unstable angina, congestive heart failure, moderate to severe valvular heart disease, severe chronic obstructive pulmonary disease (COPD)
  • (13) patient's inability to provide adequate informed consent
  • (14) patient refusal to nerve blocks and/or participation in the study
  • (15) respiratory support via ventilator post
  • (16) non English speaking
  • (17) allergy to contrast of iodine
  • (18) emergency surgery or any other non-elective procedure
  • (19) unstable vertebral and transverse process fractures
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01949480). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search